Cargando…

Are anxiety disorders associated with accelerated ageing and cognitive decline? A multicenter italian study in middle aged and older patients and controls

INTRODUCTION: Anxiety Disorders (AnxDs) are highly prevalent in middle-aged and older individuals and are putative factors that might interfere with normal aging, by affecting cognitive functioning and neuroprogression. OBJECTIVES: This study aims to assess whether current AnxD in middle-aged and ol...

Descripción completa

Detalles Bibliográficos
Autores principales: Daccò, S., Caldirola, D., Alciati, A., Fagiolini, A., Brambilla, P., Perna, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471571/
http://dx.doi.org/10.1192/j.eurpsy.2021.508
_version_ 1784789108330070016
author Daccò, S.
Caldirola, D.
Alciati, A.
Fagiolini, A.
Brambilla, P.
Perna, G.
author_facet Daccò, S.
Caldirola, D.
Alciati, A.
Fagiolini, A.
Brambilla, P.
Perna, G.
author_sort Daccò, S.
collection PubMed
description INTRODUCTION: Anxiety Disorders (AnxDs) are highly prevalent in middle-aged and older individuals and are putative factors that might interfere with normal aging, by affecting cognitive functioning and neuroprogression. OBJECTIVES: This study aims to assess whether current AnxD in middle-aged and older subjects are associated with 1) lower neuropsychological performance, 2) shorter telomere length/lower plasmatic Amyloid-Beta, and 3) brain connectivity alterations, compared to subjects without lifetime psychiatric disorders (HCs). METHODS: This is an ongoing multicentric cross-sectional study. We collected preliminary data on neuropsychological performance through a standardized battery, in 60 outpatients with current AnxDs (DSM-5 criteria), 24 with psychopharmacological treatments (AnxDs+) and 36 without (AnxDs-), compared to 76 HCs, all aged 50-75 years. This study was supported by Fondazione Cariplo, grant n° 2014:0664. RESULTS: AnxDs- patients showed poorer performance in the language domain, namely in semantic fluency (p=0.04), compared to HCs. No other significant differences were found between groups. Within the patients’ group, we found that a greater burden of psychiatric disorders or medical diseases, current use of benzodiazepines, or unhealthy lifestyle had significant detrimental effects on cognition, whereas current use of antidepressants, pharmacological treatments for medical conditions, and higher levels of physical activity exhibited the opposite effects. CONCLUSIONS: We found only limited difference in cognitive performance between patients and controls. However, our preliminary results show that multiple factors influence cognitive performance in individuals with AnxDs, making these aspect important to monitor in clinical practice. So far, our results are provisional and further analyses in the final sample may provide more reliable conclusions.
format Online
Article
Text
id pubmed-9471571
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-94715712022-09-29 Are anxiety disorders associated with accelerated ageing and cognitive decline? A multicenter italian study in middle aged and older patients and controls Daccò, S. Caldirola, D. Alciati, A. Fagiolini, A. Brambilla, P. Perna, G. Eur Psychiatry Abstract INTRODUCTION: Anxiety Disorders (AnxDs) are highly prevalent in middle-aged and older individuals and are putative factors that might interfere with normal aging, by affecting cognitive functioning and neuroprogression. OBJECTIVES: This study aims to assess whether current AnxD in middle-aged and older subjects are associated with 1) lower neuropsychological performance, 2) shorter telomere length/lower plasmatic Amyloid-Beta, and 3) brain connectivity alterations, compared to subjects without lifetime psychiatric disorders (HCs). METHODS: This is an ongoing multicentric cross-sectional study. We collected preliminary data on neuropsychological performance through a standardized battery, in 60 outpatients with current AnxDs (DSM-5 criteria), 24 with psychopharmacological treatments (AnxDs+) and 36 without (AnxDs-), compared to 76 HCs, all aged 50-75 years. This study was supported by Fondazione Cariplo, grant n° 2014:0664. RESULTS: AnxDs- patients showed poorer performance in the language domain, namely in semantic fluency (p=0.04), compared to HCs. No other significant differences were found between groups. Within the patients’ group, we found that a greater burden of psychiatric disorders or medical diseases, current use of benzodiazepines, or unhealthy lifestyle had significant detrimental effects on cognition, whereas current use of antidepressants, pharmacological treatments for medical conditions, and higher levels of physical activity exhibited the opposite effects. CONCLUSIONS: We found only limited difference in cognitive performance between patients and controls. However, our preliminary results show that multiple factors influence cognitive performance in individuals with AnxDs, making these aspect important to monitor in clinical practice. So far, our results are provisional and further analyses in the final sample may provide more reliable conclusions. Cambridge University Press 2021-08-13 /pmc/articles/PMC9471571/ http://dx.doi.org/10.1192/j.eurpsy.2021.508 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Daccò, S.
Caldirola, D.
Alciati, A.
Fagiolini, A.
Brambilla, P.
Perna, G.
Are anxiety disorders associated with accelerated ageing and cognitive decline? A multicenter italian study in middle aged and older patients and controls
title Are anxiety disorders associated with accelerated ageing and cognitive decline? A multicenter italian study in middle aged and older patients and controls
title_full Are anxiety disorders associated with accelerated ageing and cognitive decline? A multicenter italian study in middle aged and older patients and controls
title_fullStr Are anxiety disorders associated with accelerated ageing and cognitive decline? A multicenter italian study in middle aged and older patients and controls
title_full_unstemmed Are anxiety disorders associated with accelerated ageing and cognitive decline? A multicenter italian study in middle aged and older patients and controls
title_short Are anxiety disorders associated with accelerated ageing and cognitive decline? A multicenter italian study in middle aged and older patients and controls
title_sort are anxiety disorders associated with accelerated ageing and cognitive decline? a multicenter italian study in middle aged and older patients and controls
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471571/
http://dx.doi.org/10.1192/j.eurpsy.2021.508
work_keys_str_mv AT daccos areanxietydisordersassociatedwithacceleratedageingandcognitivedeclineamulticenteritalianstudyinmiddleagedandolderpatientsandcontrols
AT caldirolad areanxietydisordersassociatedwithacceleratedageingandcognitivedeclineamulticenteritalianstudyinmiddleagedandolderpatientsandcontrols
AT alciatia areanxietydisordersassociatedwithacceleratedageingandcognitivedeclineamulticenteritalianstudyinmiddleagedandolderpatientsandcontrols
AT fagiolinia areanxietydisordersassociatedwithacceleratedageingandcognitivedeclineamulticenteritalianstudyinmiddleagedandolderpatientsandcontrols
AT brambillap areanxietydisordersassociatedwithacceleratedageingandcognitivedeclineamulticenteritalianstudyinmiddleagedandolderpatientsandcontrols
AT pernag areanxietydisordersassociatedwithacceleratedageingandcognitivedeclineamulticenteritalianstudyinmiddleagedandolderpatientsandcontrols